Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

July 17, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Anticancer potential of Eclipta alba extract on colon cancer

Nano-diamonds can now help in disease detection

ICAR-NATIONAL DAIRY RESEARCH INSTITUTE

Anticancer potential of Eclipta alba extract on colon cancer
  • BiotechToday
  • World

Anticancer potential of Eclipta alba extract on colon cancer

bioxone December 1, 2020November 30, 2020

SRILAGNA SARKAR, AMITY UNIVERSITY

One of the deadliest and diagnosed diseases in the world is colon cancer. Though the last few decades have seen an improvement in colon cancer with routine screening and early detection, despite all these it still claims thousands of lives every year. The current treatments for colon cancer are through surgery and chemotherapy but these also come with exposure to toxicity. Therefore, there is urgency in demand of better therapeutics.

Plants are a great potential source of novel therapeutics, nearly 50% of current chemotherapeutic drugs come from isolated medicinal plants. A review has found Eclipta alba to possess anticancer potentials along with many other pharmacological activities. The phytochemicals of Eclipta alba were extracted from shaded dried plants, where methanol was used as a solvent. Its anticancer effects were investigated through various cancer cells including normal human lung fibroblast cells using MTT (methythiazol diphenyltetrazolium bromide) assay, and migration. Final results were analyzed using ANOVA and Dunnetts’s test. MTT assay revealed the methanolic extract of Eclipta alba, showed significant specificity against HCT-116 (human colorectal carcinoma) compared to other cancer cells. The migration and the colonogenic assays also confirmed the anticancer potential of Eclipta alba extract against HCT-116 cells along with nontoxicity WI-38 cells.

Because no such anticancer activity of this kind has been previously reported, this stands as a unique finding of its kind. With minimal or non toxicity effect it also opens up a great possibility to develop an antitumor drug candidate against the deadly colon cancer in near future.

Also read: Nano-diamonds can now help in disease detection

Source: https://www.docwirenews.com/abstracts/in-vitro-anticancer-activity-of-eclipta-alba-whole-plant-extract-on-colon-cancer-cell-hct-116/

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged a cancer drug a nontoxic cancer drug cancer Eclipta alba HCT-116 whole-plant extract anticancer drug WI-38

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

ICAR-NATIONAL DAIRY RESEARCH INSTITUTE

bioxone December 1, 2020

-Shristi Sharma, Team bioXone KARNAL-132001 (HR.) WALK-IN-INTERVIEW The Walk-in-Interview for the positions of Research Associate/Research Associate-I/Senior Research Fellow/ Junior Research Fellow/Young Professional-II & Field Investigator in the below-mentioned project/scheme will certainly be conducted at this Institute on the date/time and venue and also other details shown against positions on a contractual basis, which is co-terminus […]

Related Post

  • BiotechToday
  • World

Remdesivir resistant SARS-CoV-2!

bioxone January 6, 2021January 5, 2021

Parnad Basu, Amity University Kolkata Remdesivir (C27H35N6O8P), is a broad-spectrum antiviral medication. It is administered via injection into a vein. Before the completion of clinical trials of the COVID-19 vaccines, remdesivir will be used to fight COVID-19. Now, COVID-19 is always mutating. And it is important to study those mutations to make remdesivir more effective […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Myocardial injury in severe COVID 19 as compared to non-COVID ARDS

bioxone November 20, 2020November 20, 2020

Rohit Bhattacharjee, Amity University Kolkata Cardiac troponin elevations in COVID 19 are common in myocardial injuries, also proposed as a prognostic factor. Important knowledge gaps remain in comprehending the clinical implications and epidemiology of myocardial injury. It is also not clear whether the incidence of myocardial injury in COVID-19 patients is higher than that observed […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Identifying Host Factors to Inhibit Entry of SARS-Cov-2 And Ebola Virus

bioxone October 14, 2020October 14, 2020

Sampriti Roy, Asutosh College (University of Calcutta) When speaking of cell mechanisms, there are still a large number of the same that remain largely unknown. From understanding viral pathogenesis to antiviral therapeutics development – the identification of viral mechanisms and understanding how the virus defends itself is crucial. This is the case particularly for those […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy